Optimized fractionated radiotherapy with anti-PD-L1 and anti-TIGIT: a promising new combination.
Mathieu GrapinCorentin RichardEmeric LimagneRomain BoidotVéronique MorgandAurélie BertautValentin DerangerePierre-Antoine LaurentMarion ThibaudinJean David FumetGilles CrehangeFrançois GhiringhelliCéline MirjoletPublished in: Journal for immunotherapy of cancer (2019)
Each fractionation scheme induced different lymphoid and myeloid responses as well as various modulations of PD-L1 and TIGIT expression. Furthermore, 3x8Gy was the most effective protocol when associated with anti-PD-L1 and anti-TIGIT. This is the first study combining RT and anti-TIGIT with promising results; further studies are warranted.